{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:28Z","timestamp":1707524668557},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,5]]},"DOI":"10.7759\/cureus.29965","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T02:58:18Z","timestamp":1665025098000},"source":"Crossref","is-referenced-by-count":0,"title":["Cell-Free Fetal Deoxyribonucleic Acid (cffDNA) Analysis as a Remarkable Method of Non-Invasive Prenatal Screening"],"prefix":"10.7759","author":[{"given":"Himanshu","family":"Raj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Yelne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"United Nations. World population prospects 2019 data booklet. (2019). Accessed: August 11, 2022: https:\/\/population.un.org\/wpp\/Publications\/Files\/WPP2019_DataBooklet.pdf."},{"key":"ref2","unstructured":"Medscape. Practice essentials, background, pathophysiology. (2020). Accessed: August 11, 2022: https:\/\/emedicine.medscape.com\/article\/943216-overview."},{"key":"ref3","article-title":"Miscarriage","author":"Dugas C","year":"2022","unstructured":"Dugas C, Slane VH. Miscarriage. StatPearls , Treasure Island (FL): StatPearls Publishing; 2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2017.02.004","article-title":"Prenatal diagnosis: Screening and diagnostic tools","volume":"44","author":"Carlson LM","year":"2017","unstructured":"Carlson LM, Vora NL. Prenatal diagnosis: Screening and diagnostic tools. Obstet Gynecol Clin North Am. 2017, 44:245-56. 10.1016\/j.ogc.2017.02.004","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref5","article-title":"Amniocentesis","author":"Jindal A","year":"2020","unstructured":"Jindal A, Chaudhary C. Amniocentesis. StatPearls Publishing, Treasure Island, Florida, United states; 2020."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003252.pub2","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","volume":"9","author":"Alfirevic Z","year":"2017","unstructured":"Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017, 9:CD003252. 10.1002\/14651858.CD003252.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.03.006","article-title":"Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study","volume":"118","author":"Hsu WW","year":"2019","unstructured":"Hsu WW, Hsieh CJ, Lee CN, et al.. Complication rates after chorionic villus sampling and midtrimester amniocentesis: A 7-year national registry study. J Formos Med Assoc. 2019, 118:1107-13. 10.1016\/j.jfma.2019.03.006","journal-title":"J Formos Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-012-0232-y","article-title":"The art of fetoscopy: a step toward minimally invasive fetal therapy","volume":"62","author":"Deka D","year":"2012","unstructured":"Deka D, Dadhwal V, Gajatheepan SB, Singh A, Sharma KA, Malhotra N. The art of fetoscopy: a step toward minimally invasive fetal therapy. J Obstet Gynaecol India. 2012, 62:655-9. 10.1007\/s13224-012-0232-y","journal-title":"J Obstet Gynaecol India"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16423","article-title":"A review of cordocentesis: Percutaneous umbilical cord blood sampling","volume":"13","author":"Peddi NC","year":"2021","unstructured":"Peddi NC, Avanthika C, Vuppalapati S, Balasubramanian R, Kaur J, N CD. A review of cordocentesis: Percutaneous umbilical cord blood sampling. Cureus. 2021, 13:e16423. 10.7759\/cureus.16423","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4912","article-title":"Association of low maternal pregnancy-associated plasma protein a with adverse perinatal outcome","volume":"11","author":"Antsaklis P","year":"2019","unstructured":"Antsaklis P, Fasoulakis Z, Theodora M, Diakosavvas M, Kontomanolis EN. Association of low maternal pregnancy-associated plasma protein a with adverse perinatal outcome. Cureus. 2019, 11:e4912. 10.7759\/cureus.4912","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-012-0269-9","article-title":"First trimester maternal serum screening using biochemical markers PAPP-A and free \u03b2-hCG for Down syndrome, Patau Syndrome and Edward Syndrome","volume":"28","author":"Shiefa S","year":"2013","unstructured":"Shiefa S, Amargandhi M, Bhupendra J, Moulali S, Kristine T. First trimester maternal serum screening using biochemical markers PAPP-A and free \u03b2-hCG for Down syndrome, Patau Syndrome and Edward Syndrome. Indian J Clin Biochem. 2013, 28:3-12. 10.1007\/s12291-012-0269-9","journal-title":"Indian J Clin Biochem"},{"key":"ref12","article-title":"Human Chorionic Gonadotropin (HCG)","author":"Betz D","year":"2019","unstructured":"Betz D, Fane K. Human Chorionic Gonadotropin (HCG). StatPearls Publishing, Treasure Island, Florida, United states; 2019."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61830-5","article-title":"First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring","volume":"10","author":"Fruscalzo A","year":"2020","unstructured":"Fruscalzo A, Cividino A, Rossetti E, Maurigh A, Londero AP, Driul L. First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring. Sci Rep. 2020, 10:5131. 10.1038\/s41598-020-61830-5","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16837.1","article-title":"Recent trends in prenatal genetic screening and testing","volume":"8","author":"P\u00f6s O","year":"2019","unstructured":"P\u00f6s O, Budi\u0161 J, Szemes T. Recent trends in prenatal genetic screening and testing. F1000Res. 2019, 8:10.12688\/f1000research.16837.1","journal-title":"F1000Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/genes12040501","article-title":"Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: A narrative review","volume":"12","author":"Bedei I","year":"2021","unstructured":"Bedei I, Wolter A, Weber A, Signore F, Axt-Fliedner R. Chances and challenges of new genetic screening technologies (NIPT) in prenatal medicine from a clinical perspective: A narrative review. Genes (Basel). 2021, 12:10.3390\/genes12040501","journal-title":"Genes (Basel)"},{"key":"ref16","article-title":"Pregnancy Ultrasound Evaluation","author":"Ulrich CC","year":"2020","unstructured":"Ulrich CC, Dewald O. Pregnancy Ultrasound Evaluation. StatPearls Publishing, Treasure Island (FL); 2020."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.01.008","article-title":"The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB","volume":"106","author":"Han DS","year":"2020","unstructured":"Han DS, Ni M, Chan RW, Chan VW, Lui KO, Chiu RW, Lo YM. The biology of cell-free DNA fragmentation and the roles of DNASE1, DNASE1L3, and DFFB. Am J Hum Genet. 2020, 106:202-14. 10.1016\/j.ajhg.2020.01.008","journal-title":"Am J Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp17X691625","article-title":"Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening","volume":"67","author":"Rafi I","year":"2017","unstructured":"Rafi I, Hill M, Hayward J, Chitty LS. Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening. Br J Gen Pract. 2017, 67:298-9. 10.3399\/bjgp17X691625","journal-title":"Br J Gen Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-35214-7.00002-0","article-title":"Prenatal Diagnosis","author":"Vora NL","year":"2017","unstructured":"Vora NL, O'Brien BM. Prenatal Diagnosis. Fetal and Neonatal Physiology (Fifth Edition). Polin RA, Rowitch DH, Abman SH, Benitz WE, Fox WW (ed): Elsevier, Philadelphia, Pa; 2017. 1:14-23. 10.1016\/B978-0-323-35214-7.00002-0"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02671-8","article-title":"Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis","volume":"19","author":"Pedini P","year":"2021","unstructured":"Pedini P, Graiet H, Laget L, et al.. Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis. J Transl Med. 2021, 19:15. 10.1186\/s12967-020-02671-8","journal-title":"J Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01101-4","article-title":"Outcome of publicly funded nationwide first-tier noninvasive prenatal screening","volume":"23","author":"Van Den Bogaert K","year":"2021","unstructured":"Van Den Bogaert K, Lannoo L, Brison N, et al.. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med. 2021, 23:1137-42. 10.1038\/s41436-021-01101-4","journal-title":"Genet Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000491750","article-title":"Clinical and economic impact of adopting noninvasive prenatal testing as a primary screening method for fetal aneuploidies in the general pregnancy population","volume":"45","author":"Kostenko E","year":"2019","unstructured":"Kostenko E, Chantraine F, Vandeweyer K, et al.. Clinical and economic impact of adopting noninvasive prenatal testing as a primary screening method for fetal aneuploidies in the general pregnancy population. Fetal Diagn Ther. 2019, 45:413-23. 10.1159\/000491750","journal-title":"Fetal Diagn Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00941-y","article-title":"Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies","volume":"14","author":"La Verde M","year":"2021","unstructured":"La Verde M, De Falco L, Torella A, et al.. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies. BMC Med Genomics. 2021, 14:93. 10.1186\/s12920-021-00941-y","journal-title":"BMC Med Genomics"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/genes12040478","article-title":"Performance of cell-free DNA screening for fetal common aneuploidies and sex chromosomal abnormalities: A prospective study from a less developed autonomous region in Mainland China","volume":"12","author":"Lai Y","year":"2021","unstructured":"Lai Y, Zhu X, He S, et al.. Performance of cell-free DNA screening for fetal common aneuploidies and sex chromosomal abnormalities: A prospective study from a less developed autonomous region in Mainland China. Genes (Basel). 2021, 12:10.3390\/genes12040478","journal-title":"Genes (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010048","article-title":"Cell-free DNA screening for sex chromosome abnormalities and pregnancy outcomes, 2018-2020: A retrospective analysis","volume":"12","author":"Lu Y","year":"2022","unstructured":"Lu Y, Zhou S, Linpeng S, et al.. Cell-free DNA screening for sex chromosome abnormalities and pregnancy outcomes, 2018-2020: A retrospective analysis. J Pers Med. 2022, 12:10.3390\/jpm12010048","journal-title":"J Pers Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-020-05009-1","article-title":"Cell-free DNA screening for sex chromosomal aneuploidies in 9985 pregnancies: Italian single experience","volume":"13","author":"Margiotti K","year":"2020","unstructured":"Margiotti K, Cesta A, Dello Russo C, et al.. Cell-free DNA screening for sex chromosomal aneuploidies in 9985 pregnancies: Italian single experience. BMC Res Notes. 2020, 13:167. 10.1186\/s13104-020-05009-1","journal-title":"BMC Res Notes"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5325","article-title":"Rare autosomal trisomies: Important and not so rare","volume":"38","author":"Scott F","year":"2018","unstructured":"Scott F, Bonifacio M, Sandow R, Ellis K, Smet ME, McLennan A. Rare autosomal trisomies: Important and not so rare. Prenat Diagn. 2018, 38:765-71. 10.1002\/pd.5325","journal-title":"Prenat Diagn"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan1240","article-title":"Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease","volume":"9","author":"Pertile MD","year":"2017","unstructured":"Pertile MD, Halks-Miller M, Flowers N, et al.. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci Transl Med. 2017, 9:10.1126\/scitranslmed.aan1240","journal-title":"Sci Transl Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12521","article-title":"Cell\u2010free fetal DNA and fetal blood group genotyping: non\u2010invasive prenatal testing","volume":"15","author":"Clausen FB","year":"2019","unstructured":"Clausen FB. Cell\u2010free fetal DNA and fetal blood group genotyping: non\u2010invasive prenatal testing. ISBT Sci Ser. 2019, 15:46-51. 10.1111\/voxs.12521","journal-title":"ISBT Sci Ser"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000505464","article-title":"Next generation sequencing-based fetal ABO blood group prediction by analysis of cell-free DNA from maternal plasma","volume":"47","author":"Rieneck K","year":"2020","unstructured":"Rieneck K, Egeberg Hother C, Clausen FB, et al.. Next generation sequencing-based fetal ABO blood group prediction by analysis of cell-free DNA from maternal plasma. Transfus Med Hemother. 2020, 47:45-53. 10.1159\/000505464","journal-title":"Transfus Med Hemother"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000504348","article-title":"Introduction of noninvasive prenatal testing for blood group and platelet antigens from cell-free plasma DNA using digital PCR","volume":"47","author":"Eryilmaz M","year":"2020","unstructured":"Eryilmaz M, M\u00fcller D, Rink G, Kl\u00fcter H, Bugert P. Introduction of noninvasive prenatal testing for blood group and platelet antigens from cell-free plasma DNA using digital PCR. Transfus Med Hemother. 2020, 47:292-301. 10.1159\/000504348","journal-title":"Transfus Med Hemother"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.30.5.304","article-title":"Chromosome 22q11.2 microdeletion syndrome","volume":"30","author":"Molesky MG","year":"2011","unstructured":"Molesky MG. Chromosome 22q11.2 microdeletion syndrome. Neonatal Netw. 2011, 30:304-11. 10.1891\/0730-0832.30.5.304","journal-title":"Neonatal Netw"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2021.09.018","article-title":"Cell-free DNA test for pathogenic copy number variations: A retrospective study","volume":"60","author":"Duan HL","year":"2021","unstructured":"Duan HL, Li J, Wang WJ, et al.. Cell-free DNA test for pathogenic copy number variations: A retrospective study. Taiwan J Obstet Gynecol. 2021, 60:1066-71. 10.1016\/j.tjog.2021.09.018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1159\/000510069","article-title":"First trimester screening for common trisomies and microdeletion 22q11.2 syndrome using cell-free DNA: A prospective clinical study","volume":"47","author":"Kagan KO","year":"2020","unstructured":"Kagan KO, Hoopmann M, Pfaff T, et al.. First trimester screening for common trisomies and microdeletion 22q11.2 syndrome using cell-free DNA: A prospective clinical study. Fetal Diagn Ther. 2020, 47:841-52. 10.1159\/000510069","journal-title":"Fetal Diagn Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick JA","year":"2013","unstructured":"Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013, 33:667-74. 10.1002\/pd.4126","journal-title":"Prenat Diagn"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17330","article-title":"Rate of no result in cell-free DNA testing and its influence on test performance metrics","volume":"50","author":"Grati FR","year":"2017","unstructured":"Grati FR, Kagan KO. Rate of no result in cell-free DNA testing and its influence on test performance metrics. Ultrasound Obstet Gynecol. 2017, 50:134-7. 10.1002\/uog.17330","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2015.02.011","article-title":"Cell-free DNA screening for fetal aneuploidy as a clinical service","volume":"48","author":"Cuckle H","year":"2015","unstructured":"Cuckle H, Benn P, Pergament E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin Biochem. 2015, 48:932-41. 10.1016\/j.clinbiochem.2015.02.011","journal-title":"Clin Biochem"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening","volume":"13","author":"Hou Y","year":"2019","unstructured":"Hou Y, Yang J, Qi Y, et al.. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening. Hum Genomics. 2019, 13:62. 10.1186\/s40246-019-0244-0","journal-title":"Hum Genomics"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0000000000000342","article-title":"Cell-free DNA screening: Complexities and challenges of clinical implementation","volume":"71","author":"Grace MR","year":"2016","unstructured":"Grace MR, Hardisty E, Dotters-Katz SK, Vora NL, Kuller JA. Cell-free DNA screening: Complexities and challenges of clinical implementation. Obstet Gynecol Surv. 2016, 71:477-87. 10.1097\/OGX.0000000000000342","journal-title":"Obstet Gynecol Surv"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5555","article-title":"Sex selection and non-invasive prenatal testing: A review of current practices, evidence, and ethical issues","volume":"40","author":"Bowman-Smart H","year":"2020","unstructured":"Bowman-Smart H, Savulescu J, Gyngell C, Mand C, Delatycki MB. Sex selection and non-invasive prenatal testing: A review of current practices, evidence, and ethical issues. Prenat Diagn. 2020, 40:398-407. 10.1002\/pd.5555","journal-title":"Prenat Diagn"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110579-cell-free-fetal-deoxyribonucleic-acid-cffdna-analysis-as-a-remarkable-method-of-non-invasive-prenatal-screening","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:04Z","timestamp":1707507664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110579-cell-free-fetal-deoxyribonucleic-acid-cffdna-analysis-as-a-remarkable-method-of-non-invasive-prenatal-screening"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.29965","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,5]]}}}